Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer

Qing-li Lu , Jian Liu , Xiao-li Zhu , Wen-jia Xu

Current Medical Science ›› 2014, Vol. 34 ›› Issue (3) : 359 -362.

PDF
Current Medical Science ›› 2014, Vol. 34 ›› Issue (3) : 359 -362. DOI: 10.1007/s11596-014-1283-3
Article

Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer

Author information +
History +
PDF

Abstract

In order to investigate the expression of nerve growth factor (NGF) and hypoxia inducible factor-1α (HIF-1α) and its correlation with angiogenesis in non-small cell lung cancer (NSCLC), paraffin-embedded tissue blocks from 20 patients with NSCLC were examined. Twenty corresponding para-cancerous lung tissue specimens were obtained to serve as a control. The expression of NGF, HIF-1α, and vascular endothelial growth factor (VEGF) in the NSCLC tissues was detected by using immunohistochemistry. The microvascular density (MVD) was determined by CD31 staining. The results showed that the expression levels of NGF, HIF-1α and VEGF in the NSCLC tissues were remarkably higher than those in the para-cancerous lung tissues (P<0.05). There was significant difference in the MVD between the NSCLC tissues (9.19±1.43) and para-cancerous lung tissues (2.23±1.19) (P<0.05). There were positive correlations between NGF and VEGF, between HIF-1α and VEGF, and between NGF and HIF-1α in NSCLC tissues, with the spearman correlation coefficient being 0.588, 0.519 and 0.588, respectively. In NSCLC tissues, the MVD had a positive correlation with the three factors (P<0.05). Theses results suggest that NGF and HIF-1α are synergically involved in the angiogenesis of NSCLC.

Keywords

non-small cell lung cancer / immunohistochemistry / nerve growth factor / hypoxia inducible factor-1α / vascular endothelial growth factor / CD31 / microvascular density

Cite this article

Download citation ▾
Qing-li Lu, Jian Liu, Xiao-li Zhu, Wen-jia Xu. Expression of nerve growth factor and hypoxia inducible factor-1α and its correlation with angiogenesis in non-small cell lung cancer. Current Medical Science, 2014, 34(3): 359-362 DOI:10.1007/s11596-014-1283-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

FerlayJ, ShinHR, BrayF, et al.. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2917

[2]

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer [EB/OL]. (2012-03-05) http://www.nccn.org/professionals/physiciangls/fguide-lines.asp

[3]

SmeyneRJ, KleinR, SchnappA, et al.. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature, 1994, 368(6468): 246-249

[4]

MoserKV, ReindlM, BlasigI, et al.. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res, 2004, 1017(1–2): 53-60

[5]

CalzaL, GiardinoL, GiulianiA, et al.. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA, 2001, 98(7): 4160-4165

[6]

EmanueliC, SalisMB, PinnaA, et al.. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation, 2002, 106(17): 2257-2262

[7]

CantarellaG, LempereurL, PrestaM, et al.. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J, 2002, 16(10): 1307-1309

[8]

EggertA, GrotzerMA, IkegakiN, et al.. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med Pediatr Oncol, 2000, 35(6): 569-572

[9]

RicciA, GrecoS, MariottaS, et al.. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol, 2001, 25(4): 439-446

[10]

JeanM. How cells endure low oxygen. Science, 2004, 303(2): 1454-1456

[11]

KuwaiT, KitadaiY, TankaS, et al.. Expression of hypoxia inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer, 2003, 105(2): 176-181

[12]

RankinEB, GiacciaAJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ, 2008, 15(2): 678-685

[13]

OtrockZK, HatoumHA, AwadaAH, et al.. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol, 2009, 70(2): 93-102

[14]

KaelinWGJr.. How oxygen makes its presence felt. Genes Dev, 2002, 16(12): 1441-1445

[15]

LiuLZ, JingY, JiangLL, et al.. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway. Biochem Biophys Res Commun, 2011, 413(2): 299-305

[16]

TapiaV, GablerF, MuñozM, et al.. Tyrosine kinase A receptor (trkA): A potential marker in epithelial ovarian cancer. Gynecol Oncol, 2011, 121(1): 13-23

[17]

VumbacaF, PhoenixKN, Rodriguez-PintoD, et al.. Double-stranded RNA-binding protein regulates VEGF mRNA stability, translation and breast cancer angiogenesis. Mol Cell Biol, 2008, 28(2): 772-783

[18]

NakamuraK, TanF, LiZ, et al.. NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1α. Mol Cell Neurosci, 2011, 46(2): 498-506

[19]

RomonR, AdriaenssensE, LagadecC, et al.. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer, 2010, 9: 157

[20]

Perez-PineraP, HernandezT, Garci’a-Sua’rezO, et al.. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas. Mol Cell Biol, 2007, 295(1–2): 19-26

[21]

CamposX, MuñozY, SelmanA, et al.. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol Oncol, 2007, 104(1): 168-175

[22]

HongJ, QianT, LeQ, et al.. NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells. Mol Vis, 2012, 18: 758-764

[23]

ParkHJ, KimMN, KimJG, et al.. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta, 2007, 1773(9): 1462-1472

[24]

ReyS, SemenzaGL. Hypoxia-inducible factor-1 dependent mechanisms of vascularization and vascular remodeling. Cardiovasc Res, 2010, 86(2): 236-242

[25]

DongX, WangYS, DouGR, et al.. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLOS One, 2011, 6(4): e18481

[26]

HanzeJ, EulBG, SavaiR, et al.. RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. Bioche Biophy Res Commun, 2003, 312(3): 571-577

[27]

KimYS, JoDH, LeeH, et al.. Nerve growth factor-mediated vascular endothelial growth factor expression of astrocyte in retinal vascular development. Bioche Biophy Res Commun, 2013, 431(4): 740-745

[28]

MartensLK, KirschnerKM, WarneckeC, et al.. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem, 2007, 282(19): 14379-14388

AI Summary AI Mindmap
PDF

94

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/